Stiehm's Immune Deficiencies: Inborn Errors of Immunity
Cultured thymus tissue transplantation
Publication
, Chapter
Markert, ML; McCarthy, EA; Gupton, SE; Lim, AP
January 1, 2020
Transplantation of thymic tissue was initially attempted in the 1960s and 1970s. Long-term successes were rare but these studies served as an important foundation. Today, cultured thymus tissue transplantation (CTTT) is performed for athymic infants. Almost all CTTT recipients are infants with complete DiGeorge anomaly. CTTT is an investigational product regulated by the FDA. Duke is only center in the United States performing thymus transplantation and this chapter reviews the experience to date.
Duke Scholars
DOI
ISBN
9780128172957
Publication Date
January 1, 2020
Start / End Page
1229 / 1240
Citation
APA
Chicago
ICMJE
MLA
NLM
Markert, M. L., McCarthy, E. A., Gupton, S. E., & Lim, A. P. (2020). Cultured thymus tissue transplantation. In Stiehm’s Immune Deficiencies: Inborn Errors of Immunity (pp. 1229–1240). https://doi.org/10.1016/B978-0-12-816768-7.00059-4
Markert, M. L., E. A. McCarthy, S. E. Gupton, and A. P. Lim. “Cultured thymus tissue transplantation.” In Stiehm’s Immune Deficiencies: Inborn Errors of Immunity, 1229–40, 2020. https://doi.org/10.1016/B978-0-12-816768-7.00059-4.
Markert ML, McCarthy EA, Gupton SE, Lim AP. Cultured thymus tissue transplantation. In: Stiehm’s Immune Deficiencies: Inborn Errors of Immunity. 2020. p. 1229–40.
Markert, M. L., et al. “Cultured thymus tissue transplantation.” Stiehm’s Immune Deficiencies: Inborn Errors of Immunity, 2020, pp. 1229–40. Scopus, doi:10.1016/B978-0-12-816768-7.00059-4.
Markert ML, McCarthy EA, Gupton SE, Lim AP. Cultured thymus tissue transplantation. Stiehm’s Immune Deficiencies: Inborn Errors of Immunity. 2020. p. 1229–1240.
DOI
ISBN
9780128172957
Publication Date
January 1, 2020
Start / End Page
1229 / 1240